Envision Healthcare Corporation (NYSE:EVHC)
- Author: Salvatore Jensen Mar 02, 2017,
Mar 02, 2017, 19:55
During the same period a year ago, the firm earned $1.07 earnings per share. The company's revenue for the quarter was up 97.4% compared to the same quarter a year ago.
Envision Healthcare Corporation (NYSE:EVHC) opened at 65.59 on Thursday. Company shares have been seen trading -12.76% off of the 52 week high and 253.63% away from the 52 week low. Pacer Advisors Inc. now owns 7,045 shares of the company's stock valued at $157,000 after buying an additional 484 shares during the period. The stock price of EVHC is moving down from its 20 days moving average with -6.10% and isolated negatively from 50 days moving average with -3.23%. Whereas 1 of them predict the stock is a hold. The shares were sold at an average price of $65.00, for a total value of $97,500.00.
In related news, insider Robert Jon Coward sold 1,500 shares of the firm's stock in a transaction that occurred on Wednesday, March 1st. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The company has a Return on Assets (ROA) of 2.60%. Institutional investors own 35.96% of the company's stock.
Relative strength index (RSI-14) for Envision Healthcare Corporation's (EVHC ) is at 52.44.
Envision Healthcare Corporation's (EVHC ) stock price distance from twenty day simple moving average surged at 0.43% while its distance from fifty day simple moving average raised 3.40% along with 93.73% above distance from two hundred simple moving averages. Finally, Goldman Sachs Group, Inc. Clearline Capital LP acquired a new stake in Envision Healthcare Corporation during the second quarter worth $956,000.
For the year, the company reported a loss of $18.6 million, or 47 cents per share, swinging to a loss in the period.
Envision Healthcare Holdings, Inc. on 02/28/2017 reported its EPS as $0.36 with the analysts projecting the EPS of the stock as $0.36. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Envision Healthcare Corporation from a "hold" rating to a "sell" rating in a research report on Friday, November 25th. Jefferies Group LLC set a $32.00 target price on shares of Envision Healthcare Corporation and gave the stock a "buy" rating in a report on Sunday, December 4th.
In an analyst rating update on Wednesday shares of Envision Healthcare Holdings (NYSE:EVHC) had their rating reiterated by analysts at RBC Capital Markets. "Outperform View" rating was issued by 5 and "Underperform Signal" rating was revealed by 0. Five research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of USA and worldwide copyright and trademark law. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/03/02/envision-healthcare-corporation-evhc-issues-quarterly-earnings-results-misses-expectations-by-0-09-eps.html.
Among analysts who offered their Analysis on Envision Healthcare Holdings, Inc. Physician-led services encompass providers at more than 780 hospitals in 45 states and the District of Columbia and include leadership positions in emergency department and hospitalist services, anesthesiology, radiology, and women's and children's services, as well as offerings in general surgery and office-based medicine.